Is Peritoneal Dialysis a Better Modality than Hemodialysis for Incident Autosomal Dominant Polycystic Kidney Disease Patients?
Clinical Journal of the American Society of Nephrology · 2026-10 · 21 (10) · 1678-1680
DOI: 10.2215/cjn.0000001230 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 03.09.2026. Verfasst von Ranine Ghamrawi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida.
- Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
ORCID-Profile: Neera K Dahl
Zitieren
APA
Ghamrawi, R., & Dahl, N. K. (2026). Is Peritoneal Dialysis a Better Modality than Hemodialysis for Incident Autosomal Dominant Polycystic Kidney Disease Patients?. Clinical Journal of the American Society of Nephrology, 21(10), 1678-1680. https://doi.org/10.2215/cjn.0000001230
Vancouver
Ghamrawi R, Dahl NK. Is Peritoneal Dialysis a Better Modality than Hemodialysis for Incident Autosomal Dominant Polycystic Kidney Disease Patients?. Clinical Journal of the American Society of Nephrology. 2026;21(10):1678-1680. doi:10.2215/cjn.0000001230
BibTeX
@article{Ghamrawi2026,
author = {Ghamrawi, Ranine and Dahl, Neera K},
title = {Is Peritoneal Dialysis a Better Modality than Hemodialysis for Incident Autosomal Dominant Polycystic Kidney Disease Patients?},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
volume = {21},
number = {10},
pages = {1678--1680},
doi = {10.2215/cjn.0000001230}
}
EUVIMED